You should read the following discussion in conjunction with Management's
Discussion and Analysis of Financial Condition and Results of Operations
included in our Annual Report on Form 10-K for the year ended December 31, 2019
("Annual Report") as filed on February 28, 2020 with the U.S. Securities and
Exchange Commission ("SEC") and the Notes to Condensed Consolidated Financial
Statements included elsewhere in this report.

Information About Forward-Looking Statements



This report includes "forward-looking statements" within the meaning of the
federal securities laws. In addition, we, or our executive officers on our
behalf, may from time to time make forward-looking statements in reports and
other documents we file with the SEC or in connection with oral statements made
to the press, potential investors or others. All statements that are not
historical facts are "forward-looking statements." Forward-looking statements
may be indicated by words or phrases such as "anticipate," "estimate," "plans,"
"expects," "projects," "should," "will," "believes" or "intends" and similar
words and phrases. These statements reflect management's current beliefs and are
not guarantees of future performance. They involve risks and uncertainties that
could cause actual results to differ materially from those expressed or implied
in any forward-looking statement. Such risks and uncertainties include the
effects of the COVID-19 pandemic on our business, operations, financial results
and liquidity, including the duration and magnitude of such effects, which will
depend on numerous evolving factors that we cannot accurately predict or assess,
including: the duration and scope of the pandemic; the negative impact on global
and regional markets, economies and economic activity; actions governments,
businesses and individuals take in response to the pandemic; the effects of the
pandemic, including all of the foregoing, on our customers, suppliers, and
business partners, and how quickly economies and demand for our products and
services recover following the pandemic.

Additional examples of forward-looking statements in this report include but are
not limited to statements regarding operating results, the success of our
operating plans, our expectations regarding our ability to generate cash and
reduce debt and associated interest expense, profit and cash flow expectations,
the prospects for newly acquired businesses to be integrated and contribute to
future growth and our expectations regarding growth through acquisitions.
Important assumptions relating to the forward-looking statements include, among
others, demand for our products, the cost, timing and success of product
upgrades and new product introductions, raw material costs, expected pricing
levels, expected outcomes of pending litigation, competitive conditions and
general economic conditions. These assumptions could prove inaccurate. Although
we believe that the estimates and projections reflected in the forward-looking
statements are reasonable, our expectations may prove to be incorrect. Important
factors that could cause actual results to differ materially from estimates or
projections contained in the forward-looking statements include but are not
limited to:

•general economic conditions;
•difficulty making acquisitions and successfully integrating acquired
businesses;
•any unforeseen liabilities associated with future acquisitions;
•limitations on our business imposed by our indebtedness;
•unfavorable changes in foreign exchange rates;
•failure to effectively mitigate cybersecurity threats;
•failure to comply with new data privacy laws and regulations;
•difficulties associated with exports/imports and risks of changes to tariff
rates;
•risks and costs associated with our international sales and operations;
•rising interest rates;
•product liability and insurance risks;
•increased warranty exposure;
•future competition;
•the cyclical nature of some of our markets;
•reduction of business with large customers;
•risks associated with government contracts;
•changes in the supply of, or price for, raw materials, parts and components;
•environmental compliance costs and liabilities;
•risks and costs associated with asbestos-related litigation;
•potential write-offs of our goodwill and other intangible assets;
•our ability to successfully develop new products;
•failure to protect our intellectual property;
•the effect of, or change in, government regulations (including tax);
                                       15
--------------------------------------------------------------------------------
  Table of Contents
•economic disruption caused by terrorist attacks, health crises (such as the
COVID-19 pandemic) or other unforeseen events; and
•the factors discussed in other reports filed with the SEC.

We believe these forward-looking statements are reasonable. However, you should
not place undue reliance on any forward-looking statements, which are based on
current expectations. Further, forward-looking statements speak only as of the
date they are made, and we undertake no obligation to publicly update any of
them in light of new information or future events.

Overview

Roper Technologies, Inc. ("Roper," "we," "us" or "our") is a diversified
technology company. We operate businesses that design and develop software (both
license and SaaS) and engineered products and solutions for a variety of niche
end markets.

We pursue consistent and sustainable growth in earnings and cash flow by
emphasizing continuous improvement in the operating performance of our existing
businesses and by acquiring other businesses that offer high value-added
software, services, engineered products and solutions that we believe are
capable of achieving growth and maintaining high margins. We compete in many
niche markets and believe we are the market leader or a competitive alternative
to the market leader in most of these markets.

Critical Accounting Policies



There were no material changes during the six months ended June 30, 2020 to the
items that we disclosed as our critical accounting policies and estimates in
"Item 7. Management's Discussion and Analysis of Financial Condition and Results
of Operations" in our Annual Report.

Recently Issued Accounting Standards

Information regarding new accounting pronouncements is included in Note 2 of the Notes to Condensed Consolidated Financial Statements.

Impact of COVID-19 on our Business

A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a pandemic by the World Health Organization.



Our top priority during this pandemic is on the health and safety of our
employees. The leadership teams at our businesses continue to be proactive in
instituting safety measures that protect our employees, while maintaining
operational capabilities required to meet their customers' needs. All our
businesses with manufacturing facilities have been deemed essential businesses
and remain operational, supplying our customers with critical products.
Additionally, all of our businesses have been operational in their
work-from-home environments with limited disruption.

The spread of COVID-19 has caused us to modify our business practices, and we
may take further actions as required by governmental and other regulatory
authorities or as we determine to protect the safety or best interests of our
employees, customers, suppliers and business partners. Some changes in business
practices include, but are not limited to: restricting employee travel,
developing social distancing plans for our employees, expanding the number of
our associates who work from home, and cancelling physical participation in
meetings, events and conferences.

While we did not experience a material impact on our results in the second quarter of 2020, COVID-19 continues to present significant uncertainty in the future economic outlook of our businesses.

We operate a diverse portfolio of businesses, and, as a result, our businesses are navigating through a diverse set of challenges. Some of the impacts our businesses are experiencing from COVID-19 include, but are not limited to:



•Our businesses have been unable to visit current and potential customers in
order to solicit new business and/or provide necessary on-site installation,
implementation and training services, which has, in some cases, limited our
ability to obtain new business and effectively service existing business;
•Government restrictions on non-emergency hospital procedures resulted in
decreased (1) demand in our businesses that provide medical products used in
non-emergency procedures and (2) revenue related to pharmaceutical utilization
in post-acute healthcare settings;
                                       16
--------------------------------------------------------------------------------
  Table of Contents
•The unprecedented slowdown and/or shut down of global economy sectors and the
related uncertain timeline to reopen and recover has created a weak demand
environment for our businesses serving industrial and energy markets; and
•Some of our customers, including those in the medical field, may seek to delay
payments to us while they are addressing the numerous challenges presented by
COVID-19; to date, such delays have not impacted the timing of our cash flow and
our financial performance in a significant manner.

While our expectations for our operating results in 2020 have been lowered to
reflect the new economic environment, our businesses are taking pragmatic cost
countermeasures to manage profitability while continuing strategic investments
for long term growth.

Our financial position remains strong with $1,871 of cash on-hand as of June 30,
2020 and an undrawn $2,500 revolving line of credit. On June 22, 2020, we issued
and sold $600 aggregate principal amount of our 2.000% Senior Notes due 2030.
These funds have been, and will be, used for general corporate purposes which
may include repaying debt or financing acquisitions. Additionally, we expect our
operating cash flow generation capability to continue due to our high levels of
recurring revenue, high profitability, low capital expenditure requirements, and
low working capital requirements. We believe that existing cash balances,
together with funds generated from operations and amounts available under our
credit facility, will be sufficient to finance our operations and meet our
foreseeable cash requirements, including quarterly cash dividends and certain
strategic acquisitions through at least the next twelve months.
                                       17
--------------------------------------------------------------------------------
  Table of Contents
Results of Operations
All currency amounts are in millions, percentages are of net revenues

General

Percentages may not sum due to rounding.



The following table sets forth selected information for the periods indicated.

                                                                                                           Six months ended June
                                                 Three months ended June 30,                                        30,
                                                   2020                  2019               2020                 2019
Net revenues:
Application Software                         $       398.4           $   390.6          $   803.5          $     771.8
Network Software & Systems                           422.0               366.8              860.2                712.5
Measurement & Analytical Solutions                   363.9               408.4              729.1                810.2
Process Technologies                                 120.7               164.5              262.9                323.0
Total                                        $     1,305.0           $ 1,330.3          $ 2,655.7          $   2,617.5
Gross margin:
Application Software                                  68.7   %            67.3  %            67.7  %              66.9    %
Network Software & Systems                            67.5                68.9               67.2                 69.0
Measurement & Analytical Solutions                    60.9                58.8               59.8                 58.2
Process Technologies                                  52.7                57.4               54.1                 56.2
Total                                                 64.7                63.9               64.0                 63.4
Selling, general and administrative
expenses:
Application Software                                  40.3   %            42.0  %            41.5  %              42.3    %
Network Software & Systems                            36.5                33.7               35.9                 33.3
Measurement & Analytical Solutions                    27.1                26.9               27.3                 27.5
Process Technologies                                  38.7                22.6               31.2                 22.9
Total                                                 35.2                32.7               34.8                 32.9
Segment operating margin:
Application Software                                  28.5   %            25.2  %            26.3  %              24.6    %
Network Software & Systems                            30.9                35.2               31.3                 35.7
Measurement & Analytical Solutions                    33.8                31.9               32.5                 30.7
Process Technologies                                  14.0                34.8               22.9                 33.2
Total                                                 29.4                31.2               29.3                 30.6
Corporate administrative expenses                     (3.9)               (3.5)              (3.6)                (3.3)
Income from operations                                25.6                27.7               25.7                 27.3
Interest expense, net                                 (3.6)               (3.4)              (3.5)                (3.4)

Other income (expense), net                           (0.2)               (0.1)                 -                 (0.2)
Gain on disposal of business                             -                   -                  -                  4.6
Earnings before income taxes                          21.8                24.2               22.2                 28.3
Income taxes                                          (5.0)               (5.5)              (4.9)                (4.7)
Net earnings                                          16.8   %            18.8  %            17.3  %              23.7    %


Three months ended June 30, 2020 compared to three months ended June 30, 2019

Net revenues for the three months ended June 30, 2020 decreased by 1.9% as compared to the three months ended June 30, 2019. The decrease was the result of organic decline of 2.8%, and a negative foreign exchange impact of 0.5%, partially offset by a net acquisition/divestiture contribution of 1.4%.


                                       18
--------------------------------------------------------------------------------
  Table of Contents
In our Application Software segment, revenues were $398.4 in the second quarter
of 2020 as compared to $390.6 in the second quarter of 2019, an increase of 2%.
Organic revenues increased 1% and acquisitions accounted for 2% of our growth,
partially offset by a negative foreign exchange impact of 1%. The growth in
organic revenues was due primarily to higher perpetual license sales in our
businesses serving the healthcare markets, partially offset by declines in our
businesses serving the higher education and K-12 markets. Gross margin increased
to 68.7% in the second quarter of 2020 as compared to 67.3% in the second
quarter of 2019 and Selling, general and administrative ("SG&A") expenses as a
percentage of revenues decreased to 40.3% in the second quarter of 2020 as
compared to 42.0% in the second quarter of 2019, both due primarily to operating
leverage on higher revenue. The resulting operating margin was 28.5% in the
second quarter of 2020 as compared to 25.2% in the second quarter of 2019.

In our Network Software & Systems segment, revenues were $422.0 in the second
quarter of 2020 as compared to $366.8 in the second quarter of 2019, an increase
of 15%. Organic revenues increased 2% and acquisitions accounted for 13% of our
growth. The growth in organic revenues was led by our higher project activity at
our toll and traffic business and subscription growth at our SaaS businesses,
partially offset by declines in our businesses that provide access management
solutions. Gross margin decreased to 67.5% in the second quarter of 2020 as
compared to 68.9% in the second quarter of 2019 due primarily to revenue mix.
SG&A expenses as a percentage of revenues increased to 36.5% in the second
quarter of 2020 as compared to 33.7% in the second quarter of 2019 due primarily
to higher amortization of acquired intangibles from the acquisitions completed
in 2019. As a result, operating margin was 30.9% in the second quarter of 2020
as compared to 35.2% in the second quarter of 2019.

Our Measurement & Analytical Solutions segment revenues decreased by 11% to
$363.9 in the second quarter of 2020 as compared to $408.4 in the second quarter
of 2019. Organic revenues decreased 1%, divestitures accounted for 9%
attributable to the disposal of Gatan, Inc. ("Gatan") on October 29, 2019, and a
negative foreign exchange impact of 1%. The decline in organic revenues was due
primarily to our water meter technology business and industrial businesses,
partially offset by organic growth primarily in our medical products businesses
used in the treatment of COVID-19. Gross margin increased to 60.9% in the second
quarter of 2020 as compared to 58.8% in the second quarter of 2019 due primarily
to revenue mix. SG&A expenses as a percentage of revenues increased to 27.1% in
the second quarter of 2020 as compared to 26.9% in the second quarter of 2019
due primarily to lower operating leverage on organic revenue declines. The
resulting operating margin was 33.8% in the second quarter of 2020 as compared
to 31.9% in the second quarter of 2019.

Our Process Technologies segment revenues decreased by 27% to $120.7 in the
second quarter of 2020 as compared to $164.5 in the second quarter of 2019.
Organic revenues decreased 26%, and the negative foreign exchange impact was 1%.
The decrease in organic revenues was due to due broad-based revenue declines
across the segment led by lower demand at our businesses serving upstream oil
and gas end markets. Gross margin decreased to 52.7% in the second quarter of
2020 as compared to 57.4% in the second quarter of 2019 due primarily to lower
revenues across the businesses. SG&A expenses as a percentage of revenues
increased to 38.7% in the second quarter of 2020 as compared to 22.6% in the
second quarter of 2019 due primarily to $13.6 restructuring charge for
structural cost reduction actions taken at certain businesses and lower
operating leverage on organic revenue declines. As a result, operating margin
was 14.0% in the second quarter of 2020 as compared to 34.8% in the second
quarter of 2019.

Corporate expenses increased to $50.3, or 3.9% of revenues, in the second quarter of 2020 as compared to $46.7, or 3.5% of revenues, in the second quarter of 2019. The increase was due primarily to higher professional services expense.

Net interest expense was $47.5 for the second quarter of 2020 as compared to $45.1 for the second quarter of 2019 due to higher weighted average debt balances, partially offset by lower weighted average interest rates.



Other expense, net, of $2.0 and $1.0 for the second quarter of 2020 and 2019,
respectively, was composed primarily of foreign exchange losses at our non-U.S.
based subsidiaries.

Income taxes as a percent of pretax earnings were 22.8% in the second quarter of
2020 as compared to 22.5% in the second quarter of 2019. The increase is due
primarily to higher state taxes in 2020 compared to 2019.

Backlog is equal to our remaining performance obligations expected to be
recognized within the next 12 months as discussed in Note 12 of the Notes to
Condensed Consolidated Financial Statements. Backlog increased 14% to $2,044.3
at June 30, 2020 as compared to $1,789.0 at June 30, 2019, organic growth was
13% and acquisitions contributed 6%, partially offset by a 5% decline related to
the disposal of the Gatan business.
                                       19

--------------------------------------------------------------------------------


  Table of Contents
                                              Backlog as of
                                                 June 30,
                                           2020            2019
Application Software                   $   870.3       $   804.1
Network Software & Systems                 832.9           585.8
Measurement & Analytical Solutions         231.4           277.2
Process Technologies                       109.7           121.9
Total                                  $ 2,044.3       $ 1,789.0

Six months ended June 30, 2020 compared to six months ended June 30, 2019



Net revenues for the six months ended June 30, 2020 increased by 1.5% as
compared to the six months ended June 30, 2019. The increase was the result of
organic growth of 0.4%, and a net acquisitions/divestiture contribution of 1.6%,
partially offset by a negative foreign exchange impact of 0.4%.

In our Application Software segment, revenues were $803.5 in the six months
ended June 30, 2020 as compared to $771.8 in the six months ended June 30, 2019,
an increase of 4%. Organic revenues increased 3% and acquisitions accounted for
2% of our growth, partially offset by a negative foreign exchange impact of 1%.
The growth in organic revenues was primarily due to businesses serving
healthcare and government contracting markets. Gross margin increased to 67.7%
in the six months ended June 30, 2020 as compared to 66.9% in the six months
ended June 30, 2019 and SG&A expenses decreased as a percentage of revenue to
41.5% in the six months ended June 30, 2020 as compared to 42.3% in the six
months ended June 30, 2019 due primarily to operating leverage on higher organic
revenues. The resulting operating margin was 26.3% in the six months ended
June 30, 2020 as compared to 24.6% in the six months ended June 30, 2019.

In our Network Software & Systems segment, revenues increased by 21% to $860.2
in the six months ended June 30, 2020 as compared to $712.5 in the six months
ended June 30, 2019. Organic revenues increased 5% and acquisitions accounted
for 16%. The growth in organic revenues was led by our higher project activity
at our toll and traffic business and subscription growth at our SaaS businesses.
Gross margin decreased to 67.2% in the six months ended June 30, 2020 as
compared to 69.0% in the six months ended June 30, 2019 due primarily to revenue
mix. SG&A expenses increased as a percentage of revenues at 35.9% in the six
months ended June 30, 2020 as compared to 33.3% in the six months ended June 30,
2019 due primarily to higher amortization of acquired intangibles from the
acquisitions completed in 2019. As a result, operating margin was 31.3% in the
six months ended June 30, 2020 as compared to 35.7% in the six months ended
June 30, 2019.

Our Measurement and Analytical segment revenues decreased by 10% to $729.1 in
the six months ended June 30, 2020 as compared to $810.2 in the six months ended
June 30, 2019. Organic revenues increased 1%, more than offset by a decrease in
revenue of 11% attributable to the disposal of the Imaging and Gatan businesses
as discussed above, and a negative foreign exchange impact of 1%. The growth in
organic revenues was due to our medical products businesses, partially offset by
our water meter technology and industrial business declines. Gross margin
increased to 59.8% in the six months ended June 30, 2020 as compared to 58.2% in
the six months ended June 30, 2019. SG&A expenses as a percentage of revenues
decreased to 27.3% in the six months ended June 30, 2020 as compared to 27.5% in
the six months ended June 30, 2019 due primarily to revenue mix. The resulting
operating margin was 32.5% in the six months ended June 30, 2020 as compared to
30.7% in the six months ended June 30, 2019.

Our Process Technologies segment revenues decreased by 19% to $262.9 in the six
months ended June 30, 2020 as compared to $323.0 in the six months ended
June 30, 2019. Organic revenues decreased by 18%, and the negative foreign
exchange impact was 1%. The decrease in organic revenues was due to due
broad-based revenue declines across the segment led by lower demand at our
businesses serving upstream oil and gas end markets. Gross margin decreased to
54.1% in the six months ended June 30, 2020 as compared to 56.2% in the six
months ended June 30, 2019 due primarily to lower revenues. SG&A expenses as a
percentage of revenues decreased to 31.2% in the six months ended June 30, 2020
as compared to 22.9% in the six months ended June 30, 2019 due primarily to
$13.6 restructuring charge for structural cost reduction actions taken at
certain of our businesses and lower operating leverage on organic revenue
declines. As a result, operating margin was 22.9% in the six months ended
June 30, 2020 as compared to 33.2% in the six months ended June 30, 2019.

Corporate expenses increased to $94.7, or 3.6% of revenues, in the six months
ended June 30, 2020 as compared to $85.2, or 3.3% of revenues, in the six months
ended June 30, 2019. The dollar increase was due primarily to higher
professional services expenses, stock compensation expenses and
acquisition-related expenses.
                                       20

--------------------------------------------------------------------------------

Table of Contents

Net interest expense was $92.9 for the six months ended June 30, 2020 as compared to $88.8 for the six months ended June 30, 2019 due to higher weighted average debt balances, partially offset by lower weighted average interest rates.



Other expense, net, of $1.2 and $4.1 for the six months ended June 30, 2020 and
2019, respectively, was composed primarily of foreign exchange losses at our
non-U.S. based subsidiaries.

Gain on disposal of business, of $119.6 in the first quarter of 2019 is the pretax gain recognized on the sale of the Imaging businesses, which closed February 5, 2019.



Income taxes as a percent of pretax earnings increased to 21.9% in the six
months ended June 30, 2020 as compared to 16.5% in the six months ended June 30,
2019. The increase is due primarily to the recognition of a discrete tax benefit
of $41.0 during the six months ended June 30, 2019.

Financial Condition, Liquidity and Capital Resources All currency amounts are in millions



Selected cash flows for the six months ended June 30, 2020 and 2019 were as
follows:
                                     Six months ended June 30,
Cash provided by/(used in):         2020                      2019
Operating activities          $      813.0                 $ 591.1
Investing activities                (177.5)                 (354.1)
Financing activities                 532.9                  (282.9)



Operating activities - Net cash provided by operating activities increased by
37.5% to $813.0 in the six months ended June 30, 2020 as compared to $591.1 in
the six months ended June 30, 2019 due primarily to (i) the deferral of $137.5
of tax payments comprised of $123.9 of US Federal and state income tax payments
that were deferred into the third quarter of 2020 and $13.7 of second quarter
2020 employer social security payroll taxes that are payable in installments in
2021 and 2022 under the CARES Act, (ii) cash taxes paid of $39.4 on the disposal
of the Imaging businesses in the first six months of 2019 as compared to $10.0
of cash taxes paid on the disposal of Gatan during the first six months of 2020,
and (iii) improvement in working capital.

Investing activities - Cash used in investing activities during the six months
ended June 30, 2020 was primarily business acquisitions. Cash used in investing
activities during the six months ended June 30, 2019 was primarily for the
acquisition of Foundry, partially offset by proceeds from the disposal of the
Imaging businesses.

Financing activities - Cash from financing activities for the six months ended
June 30, 2020 was primarily due to net proceeds from the issuance of the 2030
Notes and net proceeds from stock based compensation, partially offset by
dividend payments. Cash used in financing activities during the six months ended
June 30, 2019 was primarily due to net repayments on our unsecured credit
facility and dividend payments, partially offset by net proceeds from stock
option exercises.
Effect of foreign currency exchange rate changes on cash - Cash and cash
equivalents decreased during the six months ended June 30, 2020 by $7.3 due
primarily to the strengthening of the U.S. dollar against the functional
currencies of our United Kingdom and Canadian subsidiaries. Cash and cash
equivalents increased during the six months ended June 30, 2019 by $2.3 due
primarily to the strengthening of the Canadian dollar against the U.S. dollar.

We are also participating in certain legislative provisions to improve our
liquidity. Under these provisions we deferred approximately $320 of U.S. and
state income tax payments from the second quarter to the third quarter of 2020,
including approximately $190 of deferred U.S. income tax payments associated
with the gain on sale of Gatan. Additionally, under the U.S. Coronavirus Aid,
Relief, and Economic Security ("CARES") Act, we deferred approximately $14 of
employer social security payroll tax payments in the second quarter of 2020 and
expect to defer an additional $28 during the remainder of 2020 to be paid
equally in the fourth quarters of 2021 and 2022.
                                       21
--------------------------------------------------------------------------------
  Table of Contents
Total debt at June 30, 2020 consisted of the following:

$600 3.000% senior notes due 2020               $   600.0
$500 2.800% senior notes due 2021                   500.0
$500 3.125% senior notes due 2022                   500.0
$700 3.650% senior notes due 2023                   700.0
$500 2.350% senior notes due 2024                   500.0
$300 3.850% senior notes due 2025                   300.0
$700 3.800% senior notes due 2026                   700.0
$800 4.200% senior notes due 2028                   800.0
$700 2.950% senior notes due 2029                   700.0
$600 2.000% senior notes due 2030                   600.0

Deferred finance costs                              (40.6)
Other                                                 7.0

Total debt, net of deferred finance costs 5,866.4 Less current portion

                                602.6

Long-term debt, net of deferred finance costs $ 5,263.8





The interest rate on borrowings under our $2,500.0 unsecured credit facility is
calculated based upon various recognized indices plus a margin as defined in the
credit facility. At June 30, 2020, there were no outstanding borrowings under
our unsecured credit facility. At June 30, 2020, we had $7.0 of other debt in
the form of short term borrowings, finance leases and several smaller facilities
that allow for borrowings in various foreign locations to support our non-U.S.
businesses and $69.3 of outstanding letters of credit.

Cash at our foreign subsidiaries at June 30, 2020 decreased to $196 as compared
to $292 at December 31, 2019 due primarily to the repatriation of historical
foreign earnings, partially offset by the cash generated at our foreign
subsidiaries during the six months ended June 30, 2020. We intend to repatriate
substantially all historical and future unremitted foreign earnings.

We expect existing cash and cash equivalents, cash generated by our operations
and availability under our unsecured credit facility, as well as our expected
ability to access the capital markets, will be sufficient to fund operating
requirements for the foreseeable future.

We were in compliance with all debt covenants related to our unsecured credit facility throughout the six months ended June 30, 2020.



Net working capital (total current assets, excluding cash, less total current
liabilities, excluding debt) was negative $587.6 at June 30, 2020 as compared to
negative $505.4 at December 31, 2019, reflecting a decrease in working capital
due primarily to an increase in income taxes payable and a decrease in accounts
receivable, partially offset by an increase in unbilled receivables and a
decrease in accrued compensation. Consistent negative net working capital
demonstrates Roper's continued evolution and focus on asset-light business
models. Total debt was $5,866.4 at June 30, 2020 as compared to $5,275.3 at
December 31, 2019, due primarily to the issuance of the 2030 Notes. Our leverage
is shown in the following table:
                                   June 30,        December 31,
                                     2020              2019
Total debt                       $  5,866.4       $   5,275.3
Cash                               (1,870.8)           (709.7)
Net debt                            3,995.6           4,565.6
Stockholders' equity                9,879.7           9,491.9
Total net capital                $ 13,875.3       $  14,057.5

Net debt / total net capital           28.8  %           32.5  %



Capital expenditures were $15.5 for the six months ended June 30, 2020 as
compared to $27.9 for the six months ended June 30, 2019. Capitalized software
expenditures were $5.2 for the six months ended June 30, 2020 as compared to
$4.9 for the
                                       22
--------------------------------------------------------------------------------
  Table of Contents
six months ended June 30, 2019. We expect the aggregate of capital expenditures
and capitalized software expenditures for the balance of the year to be
comparable to prior years as a percentage of revenues.

On April 23, 2020, the Company entered into Amendment No. 2 to Credit Agreement
(the "Amendment") to the Credit Agreement dated September 23, 2016 among the
Company, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative
agent, and the other agents and parties thereto, as previously amended December
2, 2016 (the "Credit Agreement"). The Amendment modified our gross debt to
EBITDA covenant to allow for the benefit of our cash balance to be included in
the calculation, changing the covenant to a net debt to EBITDA ratio. This
provides the Company further flexibility and capacity in executing on our
pipeline of high quality acquisition opportunities.

The Amendment amends the definition of Consolidated Total Leverage Ratio (as
defined in the Credit Agreement) to be the ratio of (a)(i) Consolidated Total
Debt (as defined in the Credit Agreement) minus (ii) the aggregate amount of
Unrestricted Cash (as defined in the Credit Agreement) to (b) Consolidated
EBITDA (as defined in the Credit Agreement). The Amendment also adds a condition
to each extension of credit through December 31, 2020, that after giving effect
to any such borrowing and intended use of such borrowing, the aggregate amount
of Unrestricted Cash may not be greater than $1,250.

There have been no material changes to our contractual obligations from those disclosed in our Annual Report other than the Amendment.

Off-Balance Sheet Arrangements



At June 30, 2020, we did not have any relationships with unconsolidated entities
or financial partnerships, such as entities often referred to as structured
finance or special purpose entities, which would have been established for the
purpose of facilitating off-balance sheet arrangements or other contractually
narrow or limited purposes.

Outlook

Current geopolitical and economic uncertainties could adversely affect our
business prospects. The COVID-19 pandemic has had, and will continue to have, an
adverse impact on our business. A significant terrorist attack, other global
conflict, or public health crisis could cause changes in world economies that
would adversely affect us. It is impossible to isolate each of these potential
factor's future effects on current economic conditions or any of our businesses.
It is also impossible to predict with any reasonable degree of certainty what or
when any additional events may occur that also would similarly disrupt the
economy and have an adverse impact on our businesses.

We maintain an active acquisition program; however, future acquisitions will be
dependent on numerous factors and it is not feasible to reasonably estimate if
or when any such acquisitions will occur and what the impact will be on our
business, financial condition and results of operations. Such acquisitions may
be financed by the use of existing credit lines, future cash flows from
operations, future divestitures, the proceeds from the issuance of new debt or
equity securities or any combination of these methods, the terms and
availability of which will be subject to market and economic conditions
generally.

We anticipate that our businesses will generate positive cash flows from
operating activities, and that these cash flows will permit the reduction of
currently outstanding debt in accordance with the repayment schedule. However,
the rate at which we can reduce our debt during 2020 (and reduce the associated
interest expense) will be affected by, among other things, the financing and
operating requirements of any new acquisitions and the financial performance of
our existing companies. None of these factors can be predicted with certainty.
                                       23

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses